Law firm files class action against Beta Bionics

Schall, Brown & Schwartz said it filed a federal securities class action against Beta Bionics and certain executives over claims tied to the company’s iLet insulin pump and FDA reporting. Investors have until Nov. 3, 2026, to seek appointment as lead plaintiff.